Morepen Laboratories Limited — Others, 07-08-2025: Copy of Newspaper Publication

Morepen Laboratories has released its unaudited consolidated and standalone financial results for the quarter ended June 30, 2025. Consolidated total income saw a decline to Rs 425.24 Cr from Rs 455.22 Cr year-on-year. Net profit after tax for the consolidated entity significantly dropped to Rs 11.41 Cr from Rs 36.17 Cr. On a standalone basis, total income increased slightly to Rs 391.28 Cr from Rs 385.64 Cr, but standalone net profit also declined sharply to Rs 8.06 Cr from Rs 35.05 Cr. This highlights a challenging quarter for profitability for the company.